SecBot SecBot
Insider Cluster (6 insiders) ·Filed Jun 30, 2026

ROIV

Roivant Sciences Ltd.
NEUTRAL
Impact 5/10
Horizonweeks Processed3mo ago
Insider cluster: 6 insiders, $30.6M total
Actionable Insight • Neutral

The cluster sell is large in absolute terms but modest relative to market cap. Monitor for any upcoming corporate events (earnings, pipeline updates) that might have prompted diversification.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
ROIV ▲ +3.14% at T+60d
NEUTRAL call +3.14% · α vs SPY +0.18% · entry $35.03 → $36.13
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
+0.29%
call +0.29% · α +0.42%
$35.13
settled 4mo ago
T+5d
+3.65%
call +3.65% · α +3.39%
$36.31
settled 4mo ago
T+20d
-6.17%
call -6.17% · α -3.98%
$32.87
settled 3mo ago
T+60d
+3.14%
call +3.14% · α +0.18%
$36.13
settled 5w ago

Price Chart

Loading chart...

Executive Summary

A cluster of six Roivant insiders, including the President & CIO and the President of Immunovant, sold approximately $134.5M in open-market shares over a 7-day window ending June 30, 2026. The sales represent about 0.53% of the company's $25.2B market cap, a notable but not overwhelming amount.

Key Financial Metrics

Direction
selling
Total Value
$134.5M
Insiders
6

Key Facts

  • Six insiders sold a total of ~$134.5M in open-market shares over 7 days (June 23–30, 2026).
  • President & CIO Mayukh Sukhatme sold $17.04M on June 26.
  • President & Immunovant CEO Eric Venker sold $5.08M on June 24.
  • Directors Keith Manchester, Daniel Gold, and QVT Financial each sold tens of millions.
  • Sales represent ~0.53% of Roivant's $25.2B market cap.

Financial Impact

~$134.5M in open-market insider sales over 7 days, ~0.53% of market cap

insider ownershipfloat

Risk Factors

  • Insiders may be reducing exposure ahead of a negative catalyst (e.g., clinical trial readout, regulatory setback).
  • Continued selling by multiple C-suite executives could pressure sentiment.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ROIV-1783033260183
23 reports for ROIV
Performance horizon
67% Hit rate @ T+20 4 of 6 directional calls Went positive at some point 6 of 8 best @ T+60▲ +28.81%Mar 28, 2026
Filters
Rows
Reports for ROIV — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
8-K
BULLISH ★ 7/10
$36.80awaiting T+20—$36.05 (−2.04%)
Oct 5, 2026
21d ago
Insider Cluster
BEARISH ★ 4/10
$35.53awaiting T+20—$36.05 (−1.46%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$39.77 $33.53▼ −15.69%▼ −15.89%$36.05 (−9.35%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$39.77 $33.53▼ −15.69%▼ −15.89%$36.05 (−9.35%)
Sep 17, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$39.77 $33.53▼ −15.69%▼ −15.89%$36.05 (−9.35%)
Sep 1, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$34.18 $36.57▲ +6.99%▲ +7.32%$36.05 (+5.47%)
Aug 27, 2026
8w ago
Press Release
BULLISH ★ 8/10
$37.58 $36.13▼ −3.86%▼ −3.35%$36.05 (−4.07%)
Aug 27, 2026
8w ago
Press Release
BULLISH ★ 8/10
$37.58 $36.13▼ −3.86%▼ −3.35%$36.05 (−4.07%)
Aug 26, 2026
8w ago
Press Release
BULLISH ★ 6/10
$36.75 $38.99▲ +6.10%▲ +4.89%$36.05 (−1.90%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$35.12 $34.41▼ −2.02%▼ −2.62%$36.05 (+2.65%)
Showing 10 of 23

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026